DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B

Xue-qing HU; Yuan ZHOU; Jian CHEN; Yi-yu LU; Qi-long CHEN; Yi-yang HU; Shi-bing SU

doi:10.1007/s11655-021-3279-8

Your Location：

Home >

Browse articles >

DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B

Original Article | Updated：2022-06-27

- DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B
- Chinese Journal of Integrative Medicine Vol. 28, Issue 6, Pages: 501-508(2022)
- Affiliations：
  
  1.Research Center for Traditional Chinese Medicine Complexity System, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine,Shanghai (201203), China
  2.Department of Medical Oncology,Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai (201203), China
  3.Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine,Shanghai (201203), China
  4.Department of Vascular Disease,Shanghai Traditional Chinese Medicine-Integrated Hospital,Shanghai University of Traditional Chinese Medicine, Shanghai(201203), China
  5.Department of Vascular Disease, Shanghai Traditional Chinese Medicine-Integrated Institute of Vascular Disease, Shanghai (201203), China
  6.Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai (201203), China
- Author bio：
  
  Prof. SU Shi-bing, E-mail: shibingsu07@163.com
- Funds：
- DOI：10.1007/s11655-021-3279-8
  CLC：
- Published：01 June 2022，
  
  Published Online：09 January 2021，
  
  Accepted：25 November 2019
Scan for full text
Xue-qing HU, Yuan ZHOU, Jian CHEN, et al. DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B. [J]. Chinese Journal of Integrative Medicine 28(6):501-508(2022)
DOI：

Xue-qing HU, Yuan ZHOU, Jian CHEN, et al. DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B. [J]. Chinese Journal of Integrative Medicine 28(6):501-508(2022) DOI： 10.1007/s11655-021-3279-8.

摘要

目的:

从DNA甲基化、转录及细胞因子角度

探讨慢性乙型肝炎 (慢乙肝) 患者中医证候分型的生物学基础.

方法:

检测15例慢乙肝患者 (5例肝胆湿热证、5例肝郁脾虚证、5例肝肾阴虚证)及6名健康者的全基因组DNA甲基化水平; 并检测62例慢乙肝患者 (包括15例肝胆湿热证、15例肝郁脾虚证、16例肝肾阴虚证及16例隐证) 的48种血清细胞因子水平. 经全基因组DNA甲基化水平分析

找出关键甲基化基因人白细胞抗原F (HLA-F)

采用焦磷酸测序扩大样本进一步验证其DNA甲基化水平

并通过酶联免疫吸附测定 (ELISA) 检测血清细胞因子

采用逆转录定量聚合酶链反应 (RT-qPCR) 检测HLA-F转录水平.

结果:

667个DNA甲基化位点

覆盖18

403个DNA. 肝胆湿热证、肝郁脾虚证和肝肾阴虚证患者甲基化水平之间有明显差异(

0.05 和 |Δβ value|

0.17). 与健康者比较

肝胆湿热证患者 hg19 HLA-F CHR6: 29691140 及相邻的两个位点均发生去DNA甲基化

且HLA-F转录水平上调 (

0.05)

但肝郁脾虚证中均未改变(

0.05). 在肝肾阴虚证和隐证患者中

IL-2水平高于肝胆湿热证和肝郁脾虚证. MIP-1α和MIP-1β水平在肝肾阴虚证中较高 (

0.05)

而白血病抑制因子(LIF)水平在肝胆湿热证和隐证中较高(

0.05). IL-12

MIP-1α 和MIP-1β 水平与 HLA-F mRNA 表达量呈正相关 (依次为R2=0.238

0.05; R2 = 0.224

0.05; R=0.447

0.01). 结合HLA-F转录水平及差异细胞因子提高了慢乙肝证候分型的准确性.

结论:

HLA-F 位于5' UTR区域的CpG位点去甲基化可促进HLA-F转录. HLA-F 表达与血清IL-12

MIP-1α 和 MIP-1β 水平相关

二者可能共同参与慢乙肝患者证候分型.

Abstract

Objective:

To explore the molecular bases of Chinese medicine (CM) syndrome classification in chronic hepatitis B (CHB) patients in terms of DNA methylation

transcription and cytokines.

Methods:

Genome-wide DNA methylation and 48 serum cytokines were detected in CHB patients (DNA methylation: 15 cases; serum cytokines: 62 cases) with different CM syndromes

including dampness and heat of Gan (Liver) and gallbladder (CHB1

DNA methylation: 5 cases

serum cytokines: 15 cases)

Gan stagnation and Pi (Spleen) deficiency (CHB2

DNA methylation: 5 cases

serum cytokines: 15 cases)

Gan and Shen (Kidney) yin deficiency (CHB3

DNA methylation: 5 cases

serum cytokines: 16 cases)

CHB with hidden symptoms (HS

serum cytokines:16 cases) and healthy controls (DNA methylation: 6 cases). DNA methylation of a critical gene was further validated and its mRNA expression was detected on enlarged samples. Genome-wide DNA methylation was detected using Human Methylation 450K Assay and further verified using pyrosequencing. Cytokines and mRNA expression of gene were evaluated using multiplex biometric enzyme-linked immunosorbent assay (ELISA)-based immunoassay and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

respectively.

Results:

Totally 28

667 loci

covering 18

403 genes were differently methylated among CHB1

CHB2 and CHB3 (

0.05 and |△β value|

0.17). Further validation showed that compared with HS

the hg19 CHR6: 29691140 and its closely surrounded 2 CpG loci were demethylated and its mRNA expressions were significantly up-regulated in CHB1 (

0.05). However

they remained unaltered in CHB2 (

0.05). Levels of Interleukin (IL)-12 were higher in CHB3 and HS than that in CHB1 and CHB2 groups (

0.05). Levels of macrophage inflammatory protein (MIP)-1α and MIP-1β were higher in CHB3 than other groups and leukemia inhibrtory factor level was higher in CHB1 and HS than CHB2 and CHB3 groups (

0.05). IL-12

MIP-1α and MIP-1β concentrations were positively correlated with human leukocyte antigen F (HLA-F) mRNA expression (

=0.238

0.05;

=0.224

0.05;

=0.447

0.01; respectively). Furthermore

combination of HLA-F mRNA and differential cytokines greatly improved the differentiating accuracy among CHB1

CHB2 and HS.

Conclusions:

Demethylation of CpG loci in 5' UTR of HLA-F may up-regulate its mRNA expression and HLA-F expression was associated with IL-12

MIP-1α and MIP-1β levels

indicating that HLA-F and the differential cytokines might jointly involve in the classification of CM syndromes in CHB. (Registration No. ChiCTR-RCS-13004001)

关键词

Keywords

cytokinechronic hepatitis BDNA methylationhuman leukocyte antigen FChinese medicine syndrome

references

MacLachlan JH, Locarnini S, Cowie BC. Estimating the global prevalence of hepatitis B. Lancet 2015;386:1515-1517.

Cully M. Viral infections: reinvigorating exhausted T cells in hepatitis B infection. Nat Rev Drug Discov 2017;16:240.

Chen S, Wang Z, Wan S, Huang H, Liang H. Effect of modified Xiaochaihu Decoction containing serum on HepG2.2.5 cells via the JAK2/STAT3 signaling pathway. Mol Med Rep 2017;16:7416-7422.

Huang YQ, Ma X, Wang J, Zhao YL, Wang JB, Chen Z, et al. Therapeutic efficacy and safety of paeoniae Radix Rubra Formulae in relieving hyperbilirubinemia induced by viral hepatitis: a meta-analysis. Front Pharmacol 2016;7:63.

Su SB, Jia W, Lu A, Li S. Evidence-based ZHENG: a traditional Chinese medicine syndrome 2013. Evid-Based Complement Alternat Med 2014;2014:484201.

Zhang W, Chen J, Wu M, Zhang X, Zhang M, Yue L, et al. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation. Hepatology 2017;66:398-415.

Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B. Hepatology 2017;66:2066-2077.

Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.Hepatology 2008;47:908-918.

Chen K, Liu J, Liu S, Xia M, Zhang X, Han D, et al.Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity. Cell 2017;170:492506 e414.

Hu XQ, Su SB. An overview of epigenetics in Chinese medicine researches. Chin J Integr Med 2017;23:714-720.

Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B. Chin J Hepatol 2005;12:881-891.

China Association of Chinese Medicine. Diagnostic standards of TCM syndrome for viral hepatitis (Trialed). J Tradit Chin Med 1992;5:39-40.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.

Ji Q, Luo YQ, Wang WH, Liu X, Li Q, Su SB. Research advances in traditional Chinese medicine syndromes in cancer patients. J Integr Med 2016;14:12-21.

Ji Q, Zhu F, Liu X, Li Q, Su SB. Recent advance in applications of proteomics technologies on traditional Chinese medicine research.Evid-Based Complement Alternat Med 2015;2015:983139.

Lu YY, Chen QL, Guan Y, Guo ZZ, Zhang H, Zhang W, et al.Study of ZHENG differentiation in hepatitis B-caused cirrhosis:a transcriptional profiling analysis. BMC Complement Altern Med 2014;14:371.

Chen QL, Lu YY, Zhang GB, Song YN, Zhou QM, Zhang H, et al. Progression from excessive to deficient syndromes in chronic hepatitis B: a dynamical network analysis of miRNA array data.Evid-Based Complement Alternat Med 2013;2013:945245.

Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 2014;26:577-590.

Lou S, Lee HM, Qin H, Li JW, Gao Z, Liu X, et al. Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation. Genome Biol 2014;1:408.

Monaco JJ. A molecular model of MHC class-Ⅰ-restricted antigen processing. Immunol Today 1992;13:173-179.

Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class Ⅰ and MHC class Ⅱ antigen presentation. Nat Rev Immunol 2011;11:823-836.

York IA, Rock KL. Antigen processing and presentation by the class Ⅰ major histocompatibility complex. Annu Rev Immunol 1996;14:369-396.

Goodridge JP, Lee N, Burian A, Pyo CW, Tykodi SS, Warren EH, et al. HLA-F and MHC-Ⅰ open conformers cooperate in a MHC-Ⅰ antigen cross-presentation pathway. J Immunol 2013;191:1567-1577.

Harada A, Ishigami S, Kijima Y, Nakajo A, Arigami T, Kurahara H, et al. Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer. Pathol Int 2015;65:569-574.

Ishigami S, Arigami T, Okumura H, Uchikado Y, Kita Y,Kurahara H, et al. Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer. Anticancer Res 2015;35:227985.

Zhang X, Lin A, Zhang JG, Bao WG, Xu DP, Ruan YY, et al.Alteration of HLA-F and HLA Ⅰ antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma. Int J Cancer 2013;132:82-89.

Xu Y, Han H, Zhang F, Lv S, Li Z, Fang Z. Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 2015;9:300-304.

Morandi F, Cangemi G, Barco S, Amoroso L, Giuliano M,Gigliotti AR, et al. Plasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patients.BioMed Res Intern 2013;2013:956878.

Zhang J, Pan L, Chen L, Feng X, Zhou L, Zheng S. Non-classical MHC-Iota genes in chronic hepatitis B and hepatocellular carcinoma. Immunogenetics 2012;64:251-258.

Xin A, Masson F, Liao Y, Preston S, Guan T, Gloury R, et al.A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet. Nat Immunol 2016;17:422-432.

Li X, Chaudry IH, Choudhry MA. ERK and not p38 pathway is required for IL-12 restoration of T cell IL-2 and IFN-gamma in a rodent model of alcohol intoxication and burn injury. J Immunol 2009;183:3955-3962.

Alli RS, Khar A. Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function. FEBS Lett 2004;559:71-76.

Wang Y, Gao A, Zhao H, Lu P, Cheng H, Dong F, et al.Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1alpha/CCL3. Leukemia 2016;30:1897-1908.

Kim HS, Ryu KJ, Ko YH, Kim HJ, Kim SH, Kim WS, et al.Macrophage inflammatory protein 1 alpha (MIP-1alpha) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma. Hematol Oncol 2017;35:310-316.

Llorián-Salvador M, González-Rodríguez S, Lastra A,Fernández-García MT, Hidalgo A, Menéndez L, et al.Involvement of CC chemokine receptor 1 and CCL3 in acute and chronic inflammatory pain in mice. Basic Clin Pharmacol Toxicol 2016;119:32-40.

Kumari N, Agrawal U, Mishra AK, Kumar A, Vasudeva P,Mohanty NK, et al. Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer. Tumour Biol 2017;39:1010428317697552.

Gentili A, Zaibi MS, Alomar SY, Vuono SD, Ricci MA, Alaeddin A, et al. Circulating levels of the adipokines monocyte chemotactic protein-4 (MCP-4), macrophage inflammatory protein-1beta (MIP-1beta), and eotaxin-3 in severe obesity and following bariatric surgery. Horm Metab Res 2016;48:847-853.

Tsergouli K, Papa A. Immune response in Dobrava-Belgrade virus infections. Arch Virol 2016;161:3413-3420.

Gulluoglu S, Sahin M, Tuysuz EC, Yaltirik CK, Kuskucu A, Ozkan F, et al. Leukemia inhibitory factor promotes aggressiveness of chordoma. Oncol Res 2017;25:1177-1188.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis:A Randomized Double-Blind Controlled Trial

Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine

Correlation between Characteristics of Coronary Plaque and Chinese Medicine Syndromes of Coronary Heart Disease: A Cross-Sectional Study Analysed by Intravascular Ultrasound

Chinese Medicine Regulates DNA Methylation to Treat Haematological Malignancies:A New Paradigm of "State-Target Medicine"

Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis

Related Author

No data

Related Institution

China Traditional Chinese Medicine Holdings Co. Limited

Central of Integrated Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University

Peking University Ditan Teaching Hospital

National Center for Infectious Diseases

Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰